Naba Alsaha Medical Services Company
TADAWUL:9546.SR
93 (SAR) • At close September 16, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) SAR.
| 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|
| Operating Activities: | ||||
| Net Income
| 52.382 | 28.934 | 27.528 | 26.653 |
| Depreciation & Amortization
| 9.494 | 6.765 | 6.122 | 6.09 |
| Deferred Income Tax
| 0 | 0 | 0 | 0 |
| Stock Based Compensation
| 0 | 0 | 0 | 0 |
| Change In Working Capital
| -26.039 | -1.834 | -2.71 | -30.165 |
| Accounts Receivables
| -51.505 | 1.677 | -1.127 | -29.245 |
| Inventory
| -4.49 | 0.263 | -0.786 | -0.607 |
| Accounts Payables
| 17.149 | -2.08 | 2.421 | -1.027 |
| Other Working Capital
| 12.806 | -1.695 | -3.218 | 0.714 |
| Other Non Cash Items
| -6.48 | 1.635 | -0.202 | 46.518 |
| Operating Cash Flow
| 29.358 | 35.501 | 30.738 | 6.036 |
| Investing Activities: | ||||
| Investments In Property Plant And Equipment
| -41.504 | -11.054 | -10.365 | -39.639 |
| Acquisitions Net
| -18.11 | -2.829 | 0 | 0 |
| Purchases Of Investments
| -1 | -2.829 | 0 | 0 |
| Sales Maturities Of Investments
| 0 | 0 | 0 | 0 |
| Other Investing Activites
| -3.638 | 2.829 | 0 | 0 |
| Investing Cash Flow
| -60.614 | -13.883 | -10.365 | -39.639 |
| Financing Activities: | ||||
| Debt Repayment
| -27.063 | -11 | -13.48 | -34.827 |
| Common Stock Issued
| 0 | 0 | 0 | 0 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 |
| Dividends Paid
| -2.1 | -2.1 | 0 | -1.75 |
| Other Financing Activities
| 0 | -1.685 | -1.685 | 34.827 |
| Financing Cash Flow
| 23.175 | -14.785 | -15.165 | 31.392 |
| Other Information: | ||||
| Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 3.997 |
| Net Change In Cash
| -8.081 | 6.832 | 5.208 | -2.211 |
| Cash At End Of Period
| 5.746 | 13.826 | 6.994 | 1.786 |